DEF 14A

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

November 13, 2002

Period of Report

December 12, 2002

Accession Number

0001133884-02-001118

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →